Bezafibrate (pan-PPAR) is not FDA-approved for PBC but it is used off-label for this condition (Levy et al., 2023; Houri and Hirschfield, 2024; Beuers et al., 2025). The gene discussed is PPARA; the disease is primary biliary cholangitis.